Comparing two oral medicines for new type 2 diabetes patients
Part of Hormones & metabolism clinical trials.
This study compares two oral diabetes medicines, cofrogliptin and acarbose, to see which works better and has fewer side effects in people who are new to diabetes medication. If you qualify, you would take one of these pills daily, and the study will help you manage your blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 2 diabetes and are not taking any diabetes medications right now.
- Your blood sugar control (HbA1c) is between 7.0% and 9.0% at the start of the study.
- Your body mass index (BMI) is between 18 and 35.
- You are willing to stick to same diet and exercise habits during the study.
- You have not had a heart attack, stroke, or unstable chest pain in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This trial tests two oral diabetes pills, cofrogliptin and linagliptin, when added to your current insulin treatment. The goal is to see if these pills help improve blood sugar control without causing extra side effects.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a new diabetes medicine called Enavogliflozin against an older drug, Pioglitazone, to see which works better for lowering blood sugar and improving heart health. If you have type 2 diabetes, take metformin plus another pill, and your A1C is between 7 and 10.5, this study may be an option for you.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.